BR112012000303A2 - antagonistas da via hedgehog e aplicações terapêuticas dos mesmos - Google Patents
antagonistas da via hedgehog e aplicações terapêuticas dos mesmosInfo
- Publication number
- BR112012000303A2 BR112012000303A2 BR112012000303A BR112012000303A BR112012000303A2 BR 112012000303 A2 BR112012000303 A2 BR 112012000303A2 BR 112012000303 A BR112012000303 A BR 112012000303A BR 112012000303 A BR112012000303 A BR 112012000303A BR 112012000303 A2 BR112012000303 A2 BR 112012000303A2
- Authority
- BR
- Brazil
- Prior art keywords
- therapeutic applications
- hedgehog pathway
- pathway antagonists
- antagonists
- hedgehog
- Prior art date
Links
- 241000289669 Erinaceus europaeus Species 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 230000037361 pathway Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09007726 | 2009-06-11 | ||
| PCT/EP2010/003441 WO2010142426A1 (en) | 2009-06-11 | 2010-06-09 | Hedgehog pathway antagonists and therapeutic applications thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012000303A2 true BR112012000303A2 (pt) | 2016-11-16 |
Family
ID=42331024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012000303A BR112012000303A2 (pt) | 2009-06-11 | 2010-06-09 | antagonistas da via hedgehog e aplicações terapêuticas dos mesmos |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8835648B2 (pt) |
| EP (1) | EP2440544B1 (pt) |
| JP (1) | JP2012529449A (pt) |
| KR (1) | KR20120026534A (pt) |
| CN (1) | CN102803246A (pt) |
| AR (1) | AR077050A1 (pt) |
| AU (1) | AU2010257802A1 (pt) |
| BR (1) | BR112012000303A2 (pt) |
| CA (1) | CA2765114A1 (pt) |
| IL (1) | IL216844A0 (pt) |
| MX (1) | MX2011013294A (pt) |
| RU (1) | RU2533825C2 (pt) |
| TW (1) | TW201102375A (pt) |
| WO (1) | WO2010142426A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2709203A1 (en) * | 2007-12-13 | 2009-06-18 | Siena Biotech S.P.A. | Hedgehog pathway antagonists and therapeutic applications thereof |
| EP2701699B1 (en) | 2011-04-28 | 2019-10-16 | The Broad Institute, Inc. | Inhibitors of histone deacetylase |
| JP6337255B2 (ja) * | 2012-07-27 | 2018-06-06 | ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. | ヒストンデアセチラーゼの阻害剤 |
| US9914717B2 (en) | 2012-12-20 | 2018-03-13 | The Broad Institute, Inc. | Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| TW201429969A (zh) * | 2012-12-20 | 2014-08-01 | Merck Sharp & Dohme | 作爲ｈｄｍ２抑制劑之經取代咪唑吡啶 |
| UY36547A (es) * | 2015-02-05 | 2016-06-01 | Bayer Cropscience Ag | Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas |
| US10548908B2 (en) * | 2016-09-15 | 2020-02-04 | Nostopharma, LLC | Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification |
| CN109232533A (zh) * | 2017-09-28 | 2019-01-18 | 北京越之康泰生物医药科技有限公司 | 氮杂环类衍生物、其制备方法及其医药用途 |
| WO2019062657A1 (zh) * | 2017-09-30 | 2019-04-04 | 北京越之康泰生物医药科技有限公司 | 氮杂环类衍生物、其制备方法及其医药用途 |
| CA3125731A1 (en) | 2018-01-12 | 2019-07-18 | KDAc Therapeutics, Inc. | Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancer |
| US12195432B2 (en) * | 2018-08-06 | 2025-01-14 | The Board Of Trustees Of The Leland Stanford Junior University | 2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases |
| CN113164479A (zh) | 2018-08-17 | 2021-07-23 | Ptc医疗公司 | 用于治疗胰腺癌的方法 |
| US10689360B1 (en) * | 2019-01-30 | 2020-06-23 | Insilico Medicine Ip Limited | TLR inhibitors |
| CN114790177B (zh) * | 2021-01-26 | 2024-03-26 | 首都医科大学附属北京天坛医院 | 新型Hedgehog信号通路抑制剂 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU879945A1 (ru) * | 1980-06-13 | 1998-05-27 | Институт физико-органической химии и углехимии АН Украинской ССР | Производные имидазо[4,5-c]пиридина, обладающие акарицидной активностью |
| FR2674856B1 (fr) * | 1991-04-05 | 1993-07-30 | Esteve Labor Dr | Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments. |
| DE59911249D1 (de) * | 1998-11-03 | 2005-01-13 | Abbott Gmbh & Co Kg | Substituierte 2-phenylbenzimidazole, deren herstellung und anwendung |
| JP4658473B2 (ja) * | 2001-07-27 | 2011-03-23 | キュリス，インコーポレイテッド | ヘッジホッグシグナル伝達経路メディエーター、それに関連した組成物及び利用 |
| CA2534649A1 (en) * | 2003-08-01 | 2005-02-10 | Genelabs Technologies, Inc. | Bicyclic imidazol derivatives against flaviviridae |
| EP1807074B1 (en) * | 2004-11-03 | 2013-10-23 | Curis, Inc. | Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| PE20080948A1 (es) * | 2006-07-25 | 2008-09-10 | Irm Llc | Derivados de imidazol como moduladores de la senda de hedgehog |
| KR101143246B1 (ko) * | 2007-06-29 | 2012-05-18 | 화이자 인코포레이티드 | 벤즈이미다졸 유도체 |
| CA2709203A1 (en) * | 2007-12-13 | 2009-06-18 | Siena Biotech S.P.A. | Hedgehog pathway antagonists and therapeutic applications thereof |
-
2010
- 2010-06-09 JP JP2012514381A patent/JP2012529449A/ja not_active Ceased
- 2010-06-09 US US13/377,290 patent/US8835648B2/en not_active Expired - Fee Related
- 2010-06-09 RU RU2011150250/04A patent/RU2533825C2/ru not_active IP Right Cessation
- 2010-06-09 BR BR112012000303A patent/BR112012000303A2/pt not_active IP Right Cessation
- 2010-06-09 MX MX2011013294A patent/MX2011013294A/es active IP Right Grant
- 2010-06-09 AU AU2010257802A patent/AU2010257802A1/en not_active Abandoned
- 2010-06-09 WO PCT/EP2010/003441 patent/WO2010142426A1/en not_active Ceased
- 2010-06-09 KR KR1020117029632A patent/KR20120026534A/ko not_active Withdrawn
- 2010-06-09 CA CA2765114A patent/CA2765114A1/en not_active Abandoned
- 2010-06-09 CN CN2010800256535A patent/CN102803246A/zh active Pending
- 2010-06-09 EP EP10724710.8A patent/EP2440544B1/en active Active
- 2010-06-10 AR ARP100102048A patent/AR077050A1/es unknown
- 2010-06-10 TW TW099118879A patent/TW201102375A/zh unknown
-
2011
- 2011-12-08 IL IL216844A patent/IL216844A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012529449A (ja) | 2012-11-22 |
| IL216844A0 (en) | 2012-03-01 |
| CN102803246A (zh) | 2012-11-28 |
| EP2440544A1 (en) | 2012-04-18 |
| AR077050A1 (es) | 2011-07-27 |
| MX2011013294A (es) | 2012-01-12 |
| WO2010142426A1 (en) | 2010-12-16 |
| TW201102375A (en) | 2011-01-16 |
| RU2011150250A (ru) | 2013-07-20 |
| RU2533825C2 (ru) | 2014-11-20 |
| US20120088752A1 (en) | 2012-04-12 |
| EP2440544B1 (en) | 2013-08-14 |
| KR20120026534A (ko) | 2012-03-19 |
| CA2765114A1 (en) | 2010-12-16 |
| AU2010257802A1 (en) | 2012-01-12 |
| US8835648B2 (en) | 2014-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012000303A2 (pt) | antagonistas da via hedgehog e aplicações terapêuticas dos mesmos | |
| BRPI1015124A2 (pt) | compostos aromáticos substituídos e usos farmacêuticos dos mesmos | |
| IL206298A0 (en) | Hedgehog pathway antagonists and therapeutic applications thereof | |
| BR112012006501A2 (pt) | polipeptídios e usos dos mesmos | |
| DK2414011T3 (da) | Medikamentafgivelsesindretning | |
| BR112012001260A2 (pt) | conjugados de epsilon-polilisina e o emprego dos mesmos | |
| DE602007000323D1 (de) | Abgabe von therapeutischen Vorrichtungen | |
| DK2296732T3 (da) | Medikamentafgivelsesindretning | |
| BRPI1011404A2 (pt) | mutantes e usos dos mesmos | |
| BR112013013167A2 (pt) | inibidores de bromodomínio e usos dos mesmos | |
| HRP20160579T1 (hr) | Spoj indola i njegova farmaceutska upotreba | |
| BRPI1015947A2 (pt) | dispositivos para distribuição de fármacos e sistemas e métodos relacionados | |
| BRPI0908906A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
| EP2132133A4 (en) | RELEASE OF PARTICULATE ACTIVE SUBSTANCES | |
| DK2493532T3 (da) | Lægemiddelfremføringsanordning | |
| BR112012004149A2 (pt) | terapia de combinação com composições de nanopartículas de taxano e inibidores de hedgehog | |
| DK2381988T3 (da) | Medikamentadministrationsanordning | |
| BRPI0920927A2 (pt) | derivados de azaquinolinona e usos dos mesmos | |
| BRPI0807544A2 (pt) | Sólido farmacêutico e dose de vacina | |
| SMT201400069B (it) | Formulazione farmaceutica | |
| EP2154966A4 (en) | BENZIMIDAZOLE AND PHARMACEUTICAL COMPOSITIONS FROM THEREOF | |
| DK2437830T4 (da) | Anordning til lægemiddelleveringsindretning og lægemiddelleveringsindretning | |
| BRPI0814599A2 (pt) | Pesticidas e usos dos mesmos | |
| BR112012007861A2 (pt) | dispositivos médicos e suas bombas | |
| PT2580240T (pt) | Anticorpos as100a4 e utilizações terapêuticas dos mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |